Several cancers including lung, melanoma, urothelial, ovarian, and colorectal express PD-L1, with a prevalence from 12% up to 100% according to tumor type, anti-PD-L1 clone, and cut-off ranges for positivity [15]. This evidence concerns the gene CD274 and melanoma.